Northwestern Mutual Wealth Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-24	Closed	–	–	2813
2019 Q1	$0	Buy	+24	New	+$271	﹤0.01%	2765
2016 Q3	–	Sell	-33	Closed	–	–	1764
2016 Q2	$0	Buy	+33	New	+$208	﹤0.01%	2329

Other funds holding STML

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Northwestern Mutual Wealth Management's STML Position: Q2 2019 in Review

Northwestern Mutual Wealth Management sold out of Stemline Therapeutics, Inc. (STML) in Q2 2019, closing a stake of 24 shares.

Northwestern Mutual Wealth Management first reported a position in STML in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 96 funds tracked by Wall St. Rank hold STML as of Q2 2019.

Northwestern Mutual Wealth Management reported no remaining Stemline Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 24 Stemline Therapeutics, Inc. shares in Q2 2019.
Northwestern Mutual Wealth Management first reported a position in Stemline Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
Northwestern Mutual Wealth Management's Stemline Therapeutics, Inc. position peaked at $0 in Q1 2019.
96 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2019.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2019, filed 12 Aug 2019.